This statement was made in response to the emergence of cases of new Atypical Progressive Acute Kidney Injury (GGAPA) here.
"The current best thing to do is to consult health workers. Do not buy medicine all by yourself for now," she remarked.
If children are sick, then the ministry suggests to bring them to health service facilities to receive medicines from doctors.
"To this day, health service facilities still use powder medicines," she remarked.
The GGAPA cases involving children emerged once again in Indonesia. After they died down at the end of 2022, they are now identified once again here, she pointed out.
From the two cases reported by the Jakarta Health Office, one patient is a disease suspect, while another one was confirmed to have died after reportedly developing fever and experiencing difficulty in urinating.
"The patients have a history of drinking syrup medicines purchased independently," she highlighted.
The patients drank the syrup medicine of the Praxion brand purchased from a pharmacy here.
Various parties are still investigating the link between the contamination of chemical compounds Ethylene Glycol/Diethylene Glycol (EG/DEG) that exceeds the safe threshold for raw materials used in syrup production with the cases that the patients experience.
While the investigation is underway, the government has taken a precautionary action by stopping the distribution of Praxion syrup medicine.
Moreover, the ministry has issued warning letters to all health offices, health service facilities, and related professional health organizations.
The letters urge these parties to be wary of the clinical signs of GGAPA and the use of syrup medicine while the investigation is ongoing.
Related news: Jakarta recommends non-drug therapy to prevent acute kidney disease
Related news: Praxion distribution halted over acute kidney injury investigation
Translator: Andi Firdaus, Fadhli Ruhman
Editor: Tia Mutiasari
Copyright © ANTARA 2023
